INS and type 2 diabetes mellitus: Furthermore, in the i.c.v. insulin studies resting MAP significantly decreased only in the T2DM rats at 2 h post‐microinjection, but this observation was not demonstrated in the i.c.v. vehicle studies (Table 2).